Scinai Immunotherapeutics Ltd. — Form D
Scinai Immunotherapeutics Ltd. of JERUSALEM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-03. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-10-03
- Form: D
- Accession: 0001013762-23-000857
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.3M
- Investors: 1
- Date of first sale: 2023-09-19
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-493666
Issuer
- Name: Scinai Immunotherapeutics Ltd.
- CIK: 0001611747
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: JERUSALEM BIOPARK, 2ND FLOOR,, JERUSALEM, L3, 9112001
- Phone: 972-8-9302529
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Yael Margolin | Director | Rehovot, L3 |
| Elad Mark | Executive Officer | JERUSALEM, L3 |
| Morris Laster | Director | JERUSALEM, L3 |
| Amir Reichman | Director | JERUSALEM, L3 |
| Amir Reichman | Executive Officer | JERUSALEM, L3 |
| Tamar Ben-Yedidia | Executive Officer | JERUSALEM, L3 |
| Adi Raviv | Director | JERUSALEM, L3 |
| Samuel Moed | Director | JERUSALEM, L3 |
| Mark Germain | Director | JERUSALEM, L3 |
| Jay Green | Director | JERUSALEM, L3 |
| Avner Rotman | Director | JERUSALEM, L3 |
| Avner Rotman | Executive Officer | JERUSALEM, L3 |
| Uri Ben Or | Executive Officer | JERUSALEM, L3 |
Other filings by this issuer (1)
More